Related Experiment Video
Updated: Jun 10, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Requirement of JIP1-mediated c-Jun N-terminal kinase activation for obesity-induced insulin resistance
Caroline Morel1, Claire L Standen, Dae Young Jung
1Howard Hughes Medical Institute, Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, MA 01605, USA.
Abstract:
The c-Jun NH(2)-terminal kinase (JNK) interacting protein 1 (JIP1) has been proposed to act as a scaffold protein that mediates JNK activation. However, recent studies have implicated JIP1 in multiple biochemical processes. Physiological roles of JIP1 that are related to the JNK scaffold function of JIP1 are therefore unclear. To test the role of JIP1 in JNK activation, we created mice with a germ line point mutation in the Jip1 gene (Thr(103) replaced with Ala) that selectively blocks JIP1-mediated JNK activation. These mutant mice exhibit a severe defect in JNK activation caused by feeding of a high-fat diet. The loss of JIP1-mediated JNK activation protected the mutant mice against obesity-induced insulin resistance. We conclude that JIP1-mediated JNK activation plays a critical role in metabolic stress regulation of the JNK signaling pathway.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Insulin: The Receptor and Signaling Pathways
Type I Diabetes II: Pathophysiology
The JAK-STAT Signaling Pathway
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
